TORL BioTherapeutics, LLC

About TORL BioTherapeutics, LLC

TORL BioTherapeutics LLC is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of cancer patients worldwide. Their mission is to transform the lives of cancer patients through innovative therapies, leveraging unique research partnerships and an experienced team.

Products & Services

TORL-1-23 (ADC):A first- and potentially best-in-class clinical-stage antibody-drug conjugate (ADC) targeting Claudin 6 (CLDN6) for the treatment of CLDN6+ solid tumors, currently in Phase 2 clinical trials with Fast Track Designation from the U.S. FDA.

TORL-4-500 (ADC):An antibody-drug conjugate targeting DLK1, currently in pre-clinical development for specific cancer indications.

Specialties

Antibody-based therapies Antibody-drug conjugates (ADCs) Cancer treatment Claudin 6 (CLDN6) targeted therapies Global clinical development Companion diagnostics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 96000000 MR: - FA: $96M FAN: 96000000	D: 2025-10-07 FD: 2025-10-07	-
2	RT: Series B-2 T: - FT: Series B-2	A: 158000000 MR: - FA: $158 million FAN: 158000000	D: 2024-04-10 FD: 2024-04-10	11 investors
3	RT: Series B T: - FT: Series B	A: 158000000 MR: - FA: $158M FAN: 158000000	D: 2023-04-13 FD: 2023-04-13	10 investors

Series C Latest

2025-10-07

$96.0M

Series B-2 2024-04-10

$158.0M

Series B 2023-04-13

$158.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mark Alles

Chairman and CEO

M

Mark Attanasio

Director

A

Anna Berkenblit

Chief Scientific and Medical Officer

H

Howard A. "Skip" Burris III

President and Chief Medical Officer, Sarah Cannon Research Institute

D

Dave Licata

Director | President | CFO | Co-Founder

N

Neil O'Brien

Director, Co-Founder, Associate Professor at UCLA

View 16 more team members with Pro

Unlock Full Team Directory

Recent News